| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $882,962 ) |
| 2025 | 2025 | Q2I LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA056255 | PARCA (a digital tool) to improve Justice and Health | 002 | 3 | NIH | 4/15/2025 | $882,962 |
| 2025 | 2024 | Q2I LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA056255 | PARCA (a digital tool) to improve Justice and Health | 001 | 2 | NIH | 4/10/2025 | $27,384 |
| 2025 | 2023 | Q2I LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA056255 | PARCA (a digital tool) to improve Justice and Health | 000 | 1 | NIH | 4/10/2025 | -$27,384 |
|
 | Issue Date FY: 2024 ( Subtotal = $791,479 ) |
| 2024 | 2024 | Q2I LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA056255 | PARCA (a digital tool) to improve Justice and Health | 001 | 2 | NIH | 4/8/2024 | $791,479 |
| 2024 | 2023 | Q2I LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA049448 | Reward-based technology to improve opioid use disorder treatment initiation after an ED visit | 001 | 3 | NIH | 5/2/2024 | $0 |
| 2024 | 2023 | Q2I LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA056255 | PARCA (a digital tool) to improve Justice and Health | 000 | 1 | NIH | 4/8/2024 | $0 |
| 2024 | 2022 | Q2I LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA049448 | Reward-based technology to improve opioid use disorder treatment initiation after an ED visit | 000 | 3 | NIH | 5/2/2024 | $0 |
| 2024 | 2021 | Q2I LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA050398 | Technology Improving Success of Medication-Assisted Treatment in Primary Care | 000 | 3 | NIH | 3/8/2024 | $0 |
|
 | Issue Date FY: 2023 ( Subtotal = $370,183 ) |
| 2023 | 2023 | Q2I LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA056255 | PARCA (a digital tool) to improve Justice and Health | 001 | 1 | NIH | 8/1/2023 | $0 |
| 2023 | 2023 | Q2I LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA056255 | PARCA (a digital tool) to improve Justice and Health | 000 | 1 | NIH | 5/1/2023 | $256,009 |
| 2023 | 2023 | Q2I LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA049448 | Reward-based technology to improve opioid use disorder treatment initiation after an ED visit | 000 | 3 | NIH | 5/22/2023 | $114,174 |
|
 | Issue Date FY: 2022 ( Subtotal = $902,836 ) |
| 2022 | 2022 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA049448 | Reward-based technology to improve opioid use disorder treatment initiation after an ED visit | 000 | 3 | NIH | 5/13/2022 | $902,836 |
|
 | Issue Date FY: 2021 ( Subtotal = $1,093,279 ) |
| 2021 | 2021 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA049448 | Reward-based technology to improve opioid use disorder treatment initiation after an ED visit | 001 | 2 | NIH | 5/28/2021 | $498,981 |
| 2021 | 2021 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA049448 | Reward-based technology to improve opioid use disorder treatment initiation after an ED visit | 003 | 2 | NIH | 9/25/2021 | $2,450 |
| 2021 | 2021 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA050398 | Technology Improving Success of Medication-Assisted Treatment in Primary Care | 001 | 3 | NIH | 8/24/2021 | $594,298 |
| 2021 | 2020 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R41DA051156 | Digital health technology improving successful community reintegration of recently released justice-involved individuals with Substance Use Disorders. | 000 | 1 | NIH | 7/25/2021 | $0 |
| 2021 | 2019 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA050398 | Technology Improving Success of Medication-Assisted Treatment in Primary Care | 000 | 1 | NIH | 12/15/2020 | $0 |
| 2021 | 2019 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA049448 | Reward-based technology to improve opioid use disorder treatment initiation after an ED visit | 000 | 1 | NIH | 5/28/2021 | $0 |
| 2021 | 2019 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA049448 | Reward-based technology to improve opioid use disorder treatment initiation after an ED visit | 002 | 1 | NIH | 9/25/2021 | -$2,450 |
|
 | Issue Date FY: 2020 ( Subtotal = $1,066,849 ) |
| 2020 | 2020 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA050398 | Technology Improving Success of Medication-Assisted Treatment in Primary Care | 005 | 2 | NIH | 9/22/2020 | $4,488 |
| 2020 | 2020 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA050398 | Technology Improving Success of Medication-Assisted Treatment in Primary Care | 003 | 2 | NIH | 7/24/2020 | $712,668 |
| 2020 | 2020 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R41DA051156 | Digital health technology improving successful community reintegration of recently released justice-involved individuals with Substance Use Disorders. | 000 | 1 | NIH | 3/10/2020 | $229,046 |
| 2020 | 2020 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R41DA051156 | Digital health technology improving successful community reintegration of recently released justice-involved individuals with Substance Use Disorders. | 001 | 1 | NIH | 6/18/2020 | $0 |
| 2020 | 2020 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA050398 | Technology Improving Success of Medication-Assisted Treatment in Primary Care | 005 | 2 | NIH | 9/22/2020 | $120,647 |
| 2020 | 2020 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA050398 | Technology Improving Success of Medication-Assisted Treatment in Primary Care | 004 | 2 | NIH | 9/11/2020 | $0 |
| 2020 | 2019 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA050398 | Technology Improving Success of Medication-Assisted Treatment in Primary Care | 000 | 1 | NIH | 11/21/2019 | $0 |
| 2020 | 2019 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA050398 | Technology Improving Success of Medication-Assisted Treatment in Primary Care | 001 | 1 | NIH | 12/20/2019 | $0 |
| 2020 | 2019 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA050398 | Technology Improving Success of Medication-Assisted Treatment in Primary Care | 002 | 1 | NIH | 7/23/2020 | $0 |
| 2020 | 2019 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA049448 | Reward-based technology to improve opioid use disorder treatment initiation after an ED visit | 000 | 1 | NIH | 1/7/2020 | $0 |
| 2020 | 2019 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA049448 | Reward-based technology to improve opioid use disorder treatment initiation after an ED visit | 001 | 1 | NIH | 9/10/2020 | $0 |
|
 | Issue Date FY: 2019 ( Subtotal = $449,986 ) |
| 2019 | 2019 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA049448 | Reward-based technology to improve opioid use disorder treatment initiation after an ED visit | 000 | 1 | NIH | 9/17/2019 | $224,986 |
| 2019 | 2019 | Q2I, LLC | 134 BIRCH DR | RINDGE | NH | 03461-5305 | CHESHIRE | USA | R42DA050398 | Technology Improving Success of Medication-Assisted Treatment in Primary Care | 000 | 1 | NIH | 9/18/2019 | $225,000 |
|
|